Szostak Nobel prize in medicine

Jack W. Szostak, a geneticist at Harvard Medical School, is one of three co-winners of the 2009 prize.

Jack Szostak

Jack Szostak | Courtesy of Massachusetts General Hospital

Professor of genetics Jack W. Szostak has won the Nobel Prize in Physiology or Medicine with Elizabeth H. Blackburn (University of California, San Francisco) and Carol W. Greider (Johns Hopkins School of Medicine). The three scientists were recognized for their work on how chromosomes are protected by telomeres and the enzyme telomerase. Szostak's home page at Harvard Medical School details his recent work on the synthesis of life on earth: "the related challenges of understanding the origin of life on the early earth, and constructing synthetic cellular life in the laboratory." His lab home page is here; he is also a Howard Hughes Medical Institute investigator, and  has a biographical page there, emphasizing his current work on the origins of life and the re-creation of the first steps in biological synthesis. Harvard's Origins of Life Initiative is described here; Szostak is one of the affiliated faculty members.

According to the Nobel press release, the trio have solved a critical part of a fundamental problem in biology: "how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes--the telomeres--and in an enzyme that forms them – telomerase."


The explanation continues:

The long, thread-like DNA molecules that carry our genes are packed into chromosomes, the telomeres being the caps on their ends. Elizabeth Blackburn and Jack Szostak discovered that a unique DNA sequence in the telomeres protects the chromosomes from degradation. Carol Greider and Elizabeth Blackburn identified telomerase, the enzyme that makes telomere DNA. These discoveries explained how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase.


If the telomeres are shortened, cells age. Conversely, if telomerase activity is high, telomere length is maintained, and cellular senescence is delayed. This is the case in cancer cells, which can be considered to have eternal life. Certain inherited diseases, in contrast, are characterized by a defective telomerase, resulting in damaged cells. The award of the Nobel Prize recognizes the discovery of a fundamental mechanism in the cell, a discovery that has stimulated the development of new therapeutic strategies.

 

Related topics

You might also like

FAS leaders say restructuring will be complete by mid-October.

The award-winning international journalist has served as interim curator since 2025.

College staff whose jobs will be changed or eliminated were notified this week.

Most popular

In her memoir All That's Unseen, Emilee Hackney explores religion, friendship, and home.

A new federal rule sparks uncertainty for graduate students.

America’s National Parks Are a $56 Billion Economic Engine

Harvard’s Linda Bilmes on measuring the economic value of public lands

Explore More From Current Issue

Singer performing on stage with a guitar, wearing a hat, and surrounded by band instruments.

Singer Elisa Smith’s whiskey-soaked voice and subversive feminism is part of the genre’s urban shift.

Colorful abstract design resembling an octopus with intricate swirls and patterns.

Growing liver implants, mapping the sense of smell, and journalism at risk

Vibrant urban scene at dusk featuring a mural on a building and illuminated structures.

The planned opening of the Goel Center in Allston for performances will be in spring of 2027.